About SUNVAX MRNA THERAPEUTICS INC.
SunVax mRNA Therapeutics is a biotechnology company focused on developing innovative mRNA medicines using lipid nanoparticle (LNP) delivery technology for applications in oncology, vaccines, autoimmune diseases, and rare diseases.
mRNA LNP formulation in vivo and in vitro for various cell typesDevelopment of cutting-edge therapies using self-amplifying mRNA (SamRNA) platformTargeted drug delivery through LNP technology for precision medicine
Is this your company?
Claim SUNVAX MRNA THERAPEUTICS INC. to unlock the federal & state contracts GovIntel's AI has matched to you right now — plus your own scored past-performance, who you're up against, and who's risky to team with.
Claim SUNVAX MRNA THERAPEUTICS INC. & see your matchesFree to claim. Takes about a minute.
Data compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate, or want this page removed? Request a correction or removal.